ASB2 targets filamins A and B to proteasomal degradation

Mélina L Heuzé, Isabelle Lamsoul, Massimiliano Baldassarre, Yatish Lad, Sophie Lévêque, Ziba Razinia, Christel Moog-Lutz, David A Calderwood, Pierre G Lutz

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The ordered series of proliferation and differentiation from hematopoietic progenitor cells is disrupted in leukemia, resulting in arrest of differentiation at immature proliferative stages. Characterizing the molecular basis of hematopoietic differentiation is therefore important for understanding and treating disease. Retinoic acid induces expression of ankyrin repeat-containing protein with a suppressor of cytokine signaling box 2 (ASB2) in acute promyelocytic leukemia cells, and ASB2 expression inhibits growth and promotes commitment, recapitulating an early step critical for differentiation. ASB2 is the specificity subunit of an E3 ubiquitin ligase complex and is proposed to exert its effects by regulating the turnover of specific proteins; however, no ASB2 substrates had been identified. Here, we report that ASB2 targets the actin-binding proteins filamin A and B for proteasomal degradation. Knockdown of endogenous ASB2 in leukemia cells delays retinoic acid-induced differentiation and filamin degradation; conversely, ASB2 expression in leukemia cells induces filamin degradation. ASB2 expression inhibits cell spreading, and this effect is recapitulated by knocking down both filamin A and filamin B. Thus, we suggest that ASB2 may regulate hematopoietic cell differentiation by modulating cell spreading and actin remodeling through targeting of filamins for degradation.

Original languageEnglish
Pages (from-to)5130-5140
Number of pages11
JournalBlood
Volume112
Issue number13
DOIs
Publication statusPublished - 15 Dec 2008

Fingerprint

Filamins
Cytokines
Degradation
Leukemia
Tretinoin
Ankyrin Repeat
Microfilament Proteins
Acute Promyelocytic Leukemia
Ubiquitin-Protein Ligases
Hematopoietic Stem Cells
Actins
Cell Differentiation
Proteins

Keywords

  • actins
  • cell adhesion
  • cell differentiation
  • cell line, tumor
  • contractile proteins
  • filamins
  • humans
  • leukemia
  • microfilament proteins
  • proteasome endopeptidase complex
  • RNA, small interfering
  • suppressor of cytokine signaling proteins
  • tretinoin

Cite this

Heuzé, M. L., Lamsoul, I., Baldassarre, M., Lad, Y., Lévêque, S., Razinia, Z., ... Lutz, P. G. (2008). ASB2 targets filamins A and B to proteasomal degradation. Blood, 112(13), 5130-5140. https://doi.org/10.1182/blood-2007-12-128744

ASB2 targets filamins A and B to proteasomal degradation. / Heuzé, Mélina L; Lamsoul, Isabelle; Baldassarre, Massimiliano; Lad, Yatish; Lévêque, Sophie; Razinia, Ziba; Moog-Lutz, Christel; Calderwood, David A; Lutz, Pierre G.

In: Blood, Vol. 112, No. 13, 15.12.2008, p. 5130-5140.

Research output: Contribution to journalArticle

Heuzé, ML, Lamsoul, I, Baldassarre, M, Lad, Y, Lévêque, S, Razinia, Z, Moog-Lutz, C, Calderwood, DA & Lutz, PG 2008, 'ASB2 targets filamins A and B to proteasomal degradation', Blood, vol. 112, no. 13, pp. 5130-5140. https://doi.org/10.1182/blood-2007-12-128744
Heuzé ML, Lamsoul I, Baldassarre M, Lad Y, Lévêque S, Razinia Z et al. ASB2 targets filamins A and B to proteasomal degradation. Blood. 2008 Dec 15;112(13):5130-5140. https://doi.org/10.1182/blood-2007-12-128744
Heuzé, Mélina L ; Lamsoul, Isabelle ; Baldassarre, Massimiliano ; Lad, Yatish ; Lévêque, Sophie ; Razinia, Ziba ; Moog-Lutz, Christel ; Calderwood, David A ; Lutz, Pierre G. / ASB2 targets filamins A and B to proteasomal degradation. In: Blood. 2008 ; Vol. 112, No. 13. pp. 5130-5140.
@article{e72f4e04ca1f43d192de7e95a3b1ba1b,
title = "ASB2 targets filamins A and B to proteasomal degradation",
abstract = "The ordered series of proliferation and differentiation from hematopoietic progenitor cells is disrupted in leukemia, resulting in arrest of differentiation at immature proliferative stages. Characterizing the molecular basis of hematopoietic differentiation is therefore important for understanding and treating disease. Retinoic acid induces expression of ankyrin repeat-containing protein with a suppressor of cytokine signaling box 2 (ASB2) in acute promyelocytic leukemia cells, and ASB2 expression inhibits growth and promotes commitment, recapitulating an early step critical for differentiation. ASB2 is the specificity subunit of an E3 ubiquitin ligase complex and is proposed to exert its effects by regulating the turnover of specific proteins; however, no ASB2 substrates had been identified. Here, we report that ASB2 targets the actin-binding proteins filamin A and B for proteasomal degradation. Knockdown of endogenous ASB2 in leukemia cells delays retinoic acid-induced differentiation and filamin degradation; conversely, ASB2 expression in leukemia cells induces filamin degradation. ASB2 expression inhibits cell spreading, and this effect is recapitulated by knocking down both filamin A and filamin B. Thus, we suggest that ASB2 may regulate hematopoietic cell differentiation by modulating cell spreading and actin remodeling through targeting of filamins for degradation.",
keywords = "actins, cell adhesion, cell differentiation, cell line, tumor, contractile proteins, filamins, humans, leukemia, microfilament proteins, proteasome endopeptidase complex, RNA, small interfering, suppressor of cytokine signaling proteins, tretinoin",
author = "Heuz{\'e}, {M{\'e}lina L} and Isabelle Lamsoul and Massimiliano Baldassarre and Yatish Lad and Sophie L{\'e}v{\^e}que and Ziba Razinia and Christel Moog-Lutz and Calderwood, {David A} and Lutz, {Pierre G}",
year = "2008",
month = "12",
day = "15",
doi = "10.1182/blood-2007-12-128744",
language = "English",
volume = "112",
pages = "5130--5140",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

TY - JOUR

T1 - ASB2 targets filamins A and B to proteasomal degradation

AU - Heuzé, Mélina L

AU - Lamsoul, Isabelle

AU - Baldassarre, Massimiliano

AU - Lad, Yatish

AU - Lévêque, Sophie

AU - Razinia, Ziba

AU - Moog-Lutz, Christel

AU - Calderwood, David A

AU - Lutz, Pierre G

PY - 2008/12/15

Y1 - 2008/12/15

N2 - The ordered series of proliferation and differentiation from hematopoietic progenitor cells is disrupted in leukemia, resulting in arrest of differentiation at immature proliferative stages. Characterizing the molecular basis of hematopoietic differentiation is therefore important for understanding and treating disease. Retinoic acid induces expression of ankyrin repeat-containing protein with a suppressor of cytokine signaling box 2 (ASB2) in acute promyelocytic leukemia cells, and ASB2 expression inhibits growth and promotes commitment, recapitulating an early step critical for differentiation. ASB2 is the specificity subunit of an E3 ubiquitin ligase complex and is proposed to exert its effects by regulating the turnover of specific proteins; however, no ASB2 substrates had been identified. Here, we report that ASB2 targets the actin-binding proteins filamin A and B for proteasomal degradation. Knockdown of endogenous ASB2 in leukemia cells delays retinoic acid-induced differentiation and filamin degradation; conversely, ASB2 expression in leukemia cells induces filamin degradation. ASB2 expression inhibits cell spreading, and this effect is recapitulated by knocking down both filamin A and filamin B. Thus, we suggest that ASB2 may regulate hematopoietic cell differentiation by modulating cell spreading and actin remodeling through targeting of filamins for degradation.

AB - The ordered series of proliferation and differentiation from hematopoietic progenitor cells is disrupted in leukemia, resulting in arrest of differentiation at immature proliferative stages. Characterizing the molecular basis of hematopoietic differentiation is therefore important for understanding and treating disease. Retinoic acid induces expression of ankyrin repeat-containing protein with a suppressor of cytokine signaling box 2 (ASB2) in acute promyelocytic leukemia cells, and ASB2 expression inhibits growth and promotes commitment, recapitulating an early step critical for differentiation. ASB2 is the specificity subunit of an E3 ubiquitin ligase complex and is proposed to exert its effects by regulating the turnover of specific proteins; however, no ASB2 substrates had been identified. Here, we report that ASB2 targets the actin-binding proteins filamin A and B for proteasomal degradation. Knockdown of endogenous ASB2 in leukemia cells delays retinoic acid-induced differentiation and filamin degradation; conversely, ASB2 expression in leukemia cells induces filamin degradation. ASB2 expression inhibits cell spreading, and this effect is recapitulated by knocking down both filamin A and filamin B. Thus, we suggest that ASB2 may regulate hematopoietic cell differentiation by modulating cell spreading and actin remodeling through targeting of filamins for degradation.

KW - actins

KW - cell adhesion

KW - cell differentiation

KW - cell line, tumor

KW - contractile proteins

KW - filamins

KW - humans

KW - leukemia

KW - microfilament proteins

KW - proteasome endopeptidase complex

KW - RNA, small interfering

KW - suppressor of cytokine signaling proteins

KW - tretinoin

U2 - 10.1182/blood-2007-12-128744

DO - 10.1182/blood-2007-12-128744

M3 - Article

C2 - 18799729

VL - 112

SP - 5130

EP - 5140

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -